Search hospitals > Arizona > Phoenix
St. Joseph's Hospital and Medical Center
Claim this profilePhoenix, Arizona 85013
Global Leader in Cancer
Global Leader in Ovarian Cancer
Conducts research for Brain Tumor
Conducts research for Ovarian Tumors
Conducts research for Recurrence
210 reported clinical trials
19 medical researchers
Summary
St. Joseph's Hospital and Medical Center is a medical facility located in Phoenix, Arizona. This center is recognized for care of Cancer, Ovarian Cancer, Brain Tumor, Ovarian Tumors, Recurrence and other specialties. St. Joseph's Hospital and Medical Center is involved with conducting 210 clinical trials across 299 conditions. There are 19 research doctors associated with this hospital, such as Nader Sanai, MD, Rajat Walia, MD, Ekokobe Fonkem, MD, and Justin Reynolds.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Ovarian Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Nader Sanai, MDSt. Joseph's Hospital and Medical Center2 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
14 reported clinical trials
18 drugs studied
Rajat Walia, MDSt. Joseph's Hospital and Medical Center1 year of reported clinical research
Studies Fibrosis
Studies Pulmonary Fibrosis
13 reported clinical trials
18 drugs studied
Ekokobe Fonkem, MDSt. Joseph's Hospital and Medical Center - Barrow Neurological Institute3 years of reported clinical research
Studies Glioblastoma
Studies Recurrence
4 reported clinical trials
24 drugs studied
Justin ReynoldsDignity Health Center for Clinical Research at St. Joseph Hospital3 years of reported clinical research
Studies Liver Disease
Studies Alpha-1 Antitrypsin Deficiency
4 reported clinical trials
6 drugs studied
Clinical Trials running at St. Joseph's Hospital and Medical Center
Glioblastoma
Brain Tumor
Meningioma
Alpha-1 Antitrypsin Deficiency
Stroke
Malignant Glioma
Heart Failure
Bronchiolitis Obliterans Syndrome
Liver Disease
Bleeding
LY3214996 + Abemaciclib
for Glioblastoma
This trial is an open-label, multicenter, Phase 0/2 trial that will enroll up to 50 participants with recurrent glioblastoma which are schedule for resection. In the lead-in cohort, a total of 10 participants will be enrolled into the proposed phase 0 clinical trial. Participants will be administered LY3214996 plus Abemaciclib prior to surgical resection of their tumor. If positive PK results are demonstrated in ≥50% of Phase 0 participants and at least 5 participants are enrolled into Phase 2, up to approximately 40 additional participants will be enrolled in the dose expansion cohort in order to achieve a total of 25 participants enrolled into Phase 2 (lead-in cohort + dose expansion).
Recruiting1 award Phase < 126 criteria
AZD1390
for Glioblastoma
This trial tests a new drug, AZD1390, combined with radiation therapy in patients with severe brain cancer. AZD1390 is designed to enhance the effectiveness of radiation in killing cancer cells.
Recruiting1 award Phase < 1
Temsirolimus Infusion
for Brain Tumor
This is a single-center, open-label, dose-escalating Phase 0 trial that will enroll participants with a confirmed diagnosed recurrent high-grade glioma (grade 3 or 4 per WHO criteria) targeting the mTOR pathway. Eligible participants will be administered a single infusion of temsirolimus through super-selective intra-arterial infusion or intravenous infusion. Participants will receive the study drug administration on the same day as the planned surgical resection of the tumor.
Recruiting1 award Phase < 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at St. Joseph's Hospital and Medical Center?
St. Joseph's Hospital and Medical Center is a medical facility located in Phoenix, Arizona. This center is recognized for care of Cancer, Ovarian Cancer, Brain Tumor, Ovarian Tumors, Recurrence and other specialties. St. Joseph's Hospital and Medical Center is involved with conducting 210 clinical trials across 299 conditions. There are 19 research doctors associated with this hospital, such as Nader Sanai, MD, Rajat Walia, MD, Ekokobe Fonkem, MD, and Justin Reynolds.